China Resources Sanjiu Medical & Pharmaceutical Co Ltd Relative Valuation - China Resources Sanjiu Medical & Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 42.06 CNY -1.71%

Market Cap: 54B CNY

Section:

Relative Value

The Relative Value of one China Resources Sanjiu Medical & Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 42.06 CNY, China Resources Sanjiu Medical & Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

China Resources Sanjiu Medical & Pharmaceutical Co Ltd Relative Value

Show

Worst Case

Base Case

Best Case

Valuation Multiples

2.1

P/S

vs History	20
vs Industry	49

Median 5Y

1.6

Industry

2.4

Forward

More Details

15.8

P/E

vs History	30
vs Industry	30

Median 5Y

13.7

Industry

20.8

Forward

15.3

More Details

12.4

P/OCF

vs History	28
vs Industry	32

Median 5Y

11.6

Industry

15.4

More Details

16.1

P/FCFE

vs History	44
vs Industry	24

Median 5Y

15.8

Industry

22.8

More Details

2.6

P/B

vs History	20
vs Industry	28

Median 5Y

1.9

Industry

More Details

1.9

EV/S

vs History	28
vs Industry	52

Median 5Y

1.4

Industry

2.5

Forward

1.8

More Details

3.5

EV/GP

vs History	28
vs Industry	53

Median 5Y

2.3

Industry

4.9

More Details

11.1

EV/EBITDA

vs History	34
vs Industry	30

Median 5Y

10.2

Industry

12.7

Forward

9.3

More Details

11.1

EV/EBIT

vs History	34
vs Industry	34

Median 5Y

10.2

Industry

15.8

Forward

More Details

11.1

EV/OCF

vs History	26
vs Industry	35

Median 5Y

10.6

Industry

More Details

13.5

EV/FCFF

vs History	50
vs Industry	27

Median 5Y

13.8

Industry

18.3

More Details

1.6

EV/IC

vs History	19
vs Industry	40

Median 5Y

1.3

Industry

1.7

More Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
CN		China Resources Sanjiu Medical & Pharmaceutical Co Ltd SZSE:000999	54B CNY	2.1	15.8	11.1	11.1
US		Eli Lilly and Co NYSE:LLY	779.4B USD	17.3	73.6	42.8	47.2
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	578.3	-15 783.5	3 846.3	17 702.3
US		Johnson & Johnson NYSE:JNJ	394B USD	4.4	28	13.1	17.2
DK		Novo Nordisk A/S CSE:NOVO B	2.1T DKK	7.2	20.8	13.7	15.6
CH		Roche Holding AG SIX:ROG	236.5B CHF	4	20.6	11.5	13.6
UK		AstraZeneca PLC LSE:AZN	177B GBP	4.2	32.6	126.9	193.9
US		Merck & Co Inc NYSE:MRK	225.9B USD	3.5	13.2	8.9	10.5
CH		Novartis AG SIX:NOVN	199.7B CHF	4.4	19	11.5	14.7
IE	E	Endo International PLC LSE:0Y5F	167.6B USD	72.3	-57.3	267.5	670.8
US		Pfizer Inc NYSE:PFE	142.8B USD	2.2	17.8	8.5	12.1

				Revenue Growth	P/S to Growth
CN		China Resources Sanjiu Medical & Pharmaceutical Co Ltd SZSE:000999	Average P/S: 63.6 2.1	11%	0.2
US		Eli Lilly and Co NYSE:LLY	17.3	22%	0.8
UK		Dechra Pharmaceuticals PLC LSE:DPH	578.3	9%	64.3
US		Johnson & Johnson NYSE:JNJ	4.4	3%	1.5
DK		Novo Nordisk A/S CSE:NOVO B	7.2	17%	0.4
CH		Roche Holding AG SIX:ROG	4	5%	0.8
UK		AstraZeneca PLC LSE:AZN	4.2	7%	0.6
US		Merck & Co Inc NYSE:MRK	3.5	5%	0.7
CH		Novartis AG SIX:NOVN	4.4	3%	1.5
IE	E	Endo International PLC LSE:0Y5F	72.3	N/A	N/A
US		Pfizer Inc NYSE:PFE	2.2	0%	N/A

				Earnings Growth	PEG
CN		China Resources Sanjiu Medical & Pharmaceutical Co Ltd SZSE:000999	Average P/E: 26.8 15.8	15%	1.1
US		Eli Lilly and Co NYSE:LLY	73.6	49%	1.5
UK		Dechra Pharmaceuticals PLC LSE:DPH	Negative Multiple: -15 783.5	N/A	N/A
US		Johnson & Johnson NYSE:JNJ	28	26%	1.1
DK		Novo Nordisk A/S CSE:NOVO B	20.8	19%	1.1
CH		Roche Holding AG SIX:ROG	20.6	16%	1.3
UK		AstraZeneca PLC LSE:AZN	32.6	36%	0.9
US		Merck & Co Inc NYSE:MRK	13.2	18%	0.7
CH		Novartis AG SIX:NOVN	19	16%	1.2
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -57.3	N/A	N/A
US		Pfizer Inc NYSE:PFE	17.8	29%	0.6

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

	Tarsus Pharmaceuticals Inc NASDAQ:TARS	51.74 USD 2.15%
	Avadel Pharmaceuticals PLC NASDAQ:AVDL	8.01 USD -1.35%
	Delcath Systems Inc NASDAQ:DCTH	13.15 USD -1.87%
	China Resources Sanjiu Medical & Pharmaceutical Co Ltd SZSE:000999	42.06 CNY -1.71%
	China Haisum Engineering Co Ltd SZSE:002116	10.07 CNY -1.37%
T	Tansun Technology Co Ltd SZSE:300872	16.01 CNY -0.81%

	Franklin Covey Co NYSE:FC	28.03 USD -0.25%
	Mohawk Industries Inc NYSE:MHK	113.74 USD -2.94%
	Ardmore Shipping Corp NYSE:ASC	10.21 USD 1.69%
	ASGN Inc NYSE:ASGN	63.02 USD -1.87%
	Skyworks Solutions Inc NASDAQ:SWKS	64.12 USD -3.29%
	Weatherford International PLC NASDAQ:WFRD	53.1 USD -2.91%

	Johnson & Johnson NYSE:JNJ	163.71 USD 0.36%
	Bank of America Corp NYSE:BAC	41.25 USD -3.08%
	Mastercard Inc NYSE:MA	540.61 USD -3.04%
	Salesforce Inc NYSE:CRM	269.97 USD -2.82%
	Abbvie Inc NYSE:ABBV	205.29 USD 1.27%
	Home Depot Inc NYSE:HD	358.15 USD -1.26%

	Arista Networks Inc NYSE:ANET	77.94 USD -1.29%
	Visa Inc NYSE:V	342.85 USD -2%
	Texas Pacific Land Corp NYSE:TPL	1 305.71 USD -1.97%
	KLA Corp NASDAQ:KLAC	673.6 USD -3.77%
	Manhattan Associates Inc NASDAQ:MANH	173.48 USD -0.77%
	Monolithic Power Systems Inc NASDAQ:MPWR	579.89 USD -3.58%

China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999

Relative Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

				EBITDA Growth	EV/EBITDA to Growth
CN		China Resources Sanjiu Medical & Pharmaceutical Co Ltd SZSE:000999	Average EV/EBITDA: 396.5 11.1	20%	0.6
US		Eli Lilly and Co NYSE:LLY	42.8	30%	1.4
UK		Dechra Pharmaceuticals PLC LSE:DPH	3 846.3	36%	106.8
US		Johnson & Johnson NYSE:JNJ	13.1	7%	1.9
DK		Novo Nordisk A/S CSE:NOVO B	13.7	15%	0.9
CH		Roche Holding AG SIX:ROG	11.5	8%	1.4
UK		AstraZeneca PLC LSE:AZN	126.9	9%	14.1
US		Merck & Co Inc NYSE:MRK	8.9	9%	1
CH		Novartis AG SIX:NOVN	11.5	5%	2.3
IE	E	Endo International PLC LSE:0Y5F	267.5	N/A	N/A
US		Pfizer Inc NYSE:PFE	8.5	3%	2.8

				EBIT Growth	EV/EBIT to Growth
CN		China Resources Sanjiu Medical & Pharmaceutical Co Ltd SZSE:000999	Average EV/EBIT: 1 700.8 11.1	16%	0.7
US		Eli Lilly and Co NYSE:LLY	47.2	33%	1.4
UK		Dechra Pharmaceuticals PLC LSE:DPH	17 702.3	98%	180.6
US		Johnson & Johnson NYSE:JNJ	17.2	12%	1.4
DK		Novo Nordisk A/S CSE:NOVO B	15.6	16%	1
CH		Roche Holding AG SIX:ROG	13.6	9%	1.5
UK		AstraZeneca PLC LSE:AZN	193.9	21%	9.2
US		Merck & Co Inc NYSE:MRK	10.5	12%	0.9
CH		Novartis AG SIX:NOVN	14.7	8%	1.8
IE	E	Endo International PLC LSE:0Y5F	670.8	N/A	N/A
US		Pfizer Inc NYSE:PFE	12.1	10%	1.2

	ServiceNow Inc NYSE:NOW	797.76 USD -3.62%
	EOG Resources Inc NYSE:EOG	126.59 USD -0.11%
	Monster Beverage Corp NASDAQ:MNST	57.86 USD -1.23%
	Copart Inc NASDAQ:CPRT	55.15 USD -0.88%
	Applied Materials Inc NASDAQ:AMAT	145.06 USD -1.77%
	Airbnb Inc NASDAQ:ABNB	120.69 USD -3.95%

52 Week Range	36.41 51.82
Price Target

China Resources Sanjiu Medical & Pharmaceutical Co Ltd SZSE:000999

Relative Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples China Resources Sanjiu Medical & Pharmaceutical Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SZSE:000999

Competitors Multiples
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Competitors